Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.
作者信息
Shapiro R, Scantlebury V P, Jordan M L, Vivas C, Gritsch H A, McCauley J, Fung J J, Hakala T R, Simmons R L, Starzl T E
机构信息
University of Pittsburgh Medical Center, Thomas E. Starzl Transplantation Institute, PA, USA.
出版信息
Transplant Proc. 1997 Sep;29(6):2737-8. doi: 10.1016/s0041-1345(97)00576-9.
Abstract
摘要
相似文献
1
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.他克莫司诱导的移植后糖尿病的可逆性：一个病例说明及文献综述
Transplant Proc. 1997 Sep;29(6):2737-8. doi: 10.1016/s0041-1345(97)00576-9.
2
Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.他克莫司在胰腺移植中的应用：一项多中心分析。他克莫司胰腺移植研究组。
Clin Transplant. 1997 Aug;11(4):299-312.
3
Tacrolimus-related microangiopathy in kidney and simultaneous pancreas-kidney recipients: evidence of endothelin and cytokine involvement.肾及胰肾联合移植受者中与他克莫司相关的微血管病：内皮素和细胞因子参与的证据
Transplant Proc. 1998 Mar;30(2):661-2. doi: 10.1016/s0041-1345(97)01452-8.
4
Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.他克莫司联合霉酚酸酯方案对肾移植受者急性排斥反应发生率及糖尿病发生情况的影响
Transplant Proc. 2004 Jan-Feb;36(1):175-7. doi: 10.1016/j.transproceed.2003.11.053.
5
Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?心脏移植后使用他克莫司或环孢素进行免疫抑制：哪种治疗在长期随访中显示出更多副作用？
Transplant Proc. 2001 Feb-Mar;33(1-2):1461-4. doi: 10.1016/s0041-1345(01)01906-6.
6
Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation.关于尸体肾移植后他克莫司与环孢素免疫抑制作用比较的述评
Transplantation. 1998 Jan 15;65(1):142-5. doi: 10.1097/00007890-199801150-00028.
7
Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study.他克莫司在原发性肾移植患者中的疗效：多中心、开放标签前瞻性研究。
Transplant Proc. 2000 Nov;32(7):1705-8. doi: 10.1016/s0041-1345(00)01406-8.
8
FK 506 dose in transplantation: from theory to practice.移植中FK 506的剂量：从理论到实践
Transplant Proc. 2001 Jun;33(4):2594-7. doi: 10.1016/s0041-1345(01)02107-8.
9
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.尸体肾移植后他克莫司（FK506）与环孢素免疫抑制作用的比较。FK506肾移植研究组。
Transplantation. 1997 Apr 15;63(7):977-83. doi: 10.1097/00007890-199704150-00013.
10
Tacrolimus (FK-506) in kidney transplantation.肾移植中的他克莫司（FK-506）。
Transplant Proc. 1997 Feb-Mar;29(1-2):45-7. doi: 10.1016/s0041-1345(96)00007-3.
引用本文的文献
1
New-Onset Diabetes Mellitus After Transplantation in a Cynomolgus Macaque (Macaca fasicularis).食蟹猴（猕猴属）移植后新发糖尿病
Comp Med. 2015 Aug;65(4):352-6.
2
Predictive factors associated with the reversibility of post-transplantation diabetes mellitus following liver transplantation.肝移植后移植后糖尿病可逆性的相关预测因素。
J Korean Med Sci. 2009 Aug;24(4):567-70. doi: 10.3346/jkms.2009.24.4.567. Epub 2009 Jul 29.
3
[Diabetes and heart transplantation].[糖尿病与心脏移植]
Clin Res Cardiol. 2006 Jan;95 Suppl 1:i48-53. doi: 10.1007/s00392-006-1121-0.
4
Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.他克莫司：其在器官移植管理中的药理学及治疗应用的进一步更新
Drugs. 2000 Feb;59(2):323-89. doi: 10.2165/00003495-200059020-00021.
5
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.他克莫司免疫抑制下停用类固醇后胰腺移植的结果。
Transplantation. 2000 Jan 27;69(2):265-71. doi: 10.1097/00007890-200001270-00012.
6
Pediatric renal transplantation under tacrolimus-based immunosuppression.基于他克莫司的免疫抑制下的小儿肾移植
Transplantation. 1999 Jan 27;67(2):299-303. doi: 10.1097/00007890-199901270-00020.
7
Long-term results of pancreas transplantation under tacrolius immunosuppression.他克莫司免疫抑制下胰腺移植的长期结果。
Transplantation. 1999 Jan 27;67(2):266-72. doi: 10.1097/00007890-199901270-00014.
本文引用的文献
1
Enteric-drained pancreas transplants monitored by fine-needle aspiration biopsy.通过细针穿刺活检监测的肠道引流式胰腺移植。
Transplant Proc. 1997 Feb-Mar;29(1-2):674-5. doi: 10.1016/s0041-1345(96)00396-x.
2
FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group.FK506用于肾移植：美国随机对照III期研究结果。FK506肾移植研究组。
Transplant Proc. 1997 Feb-Mar;29(1-2):304-5. doi: 10.1016/s0041-1345(96)00270-9.
3
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.尸体肾移植后他克莫司（FK506）与环孢素免疫抑制作用的比较。FK506肾移植研究组。
Transplantation. 1997 Apr 15;63(7):977-83. doi: 10.1097/00007890-199704150-00013.
4
Tacrolimus rescue therapy for renal allograft rejection--five-year experience.他克莫司挽救治疗肾移植排斥反应——五年经验
Transplantation. 1997 Jan 27;63(2):223-8. doi: 10.1097/00007890-199701270-00008.
5
Tacrolimus in pediatric renal transplantation.他克莫司在小儿肾移植中的应用
Transplantation. 1996 Dec 27;62(12):1752-8. doi: 10.1097/00007890-199612270-00010.
6
Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.他克莫司治疗难治性急性肾移植排斥反应：通过方案活检确定组织学反应的定义
Transplantation. 1996 Oct 15;62(7):906-10. doi: 10.1097/00007890-199610150-00006.
7
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.FK506用于胰腺移植后诱导和挽救治疗的首次经验的多中心分析。
Transplantation. 1996 Jan 27;61(2):261-73. doi: 10.1097/00007890-199601270-00018.
8
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival.FK506和环孢素对肾移植短期和长期存活的相对影响。
Transplantation. 1995 Dec 27;60(12):1384-8. doi: 10.1097/00007890-199560120-00002.
9
Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell.FK506对胰岛素转录的抑制作用以及FK506结合蛋白-12在胰腺β细胞中的可能参与情况。
Transplantation. 1995 Jun 15;59(11):1606-13.
10
Zotero 插件